{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:47:02Z","timestamp":1793764022387,"version":"4.6.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T00:00:00Z","timestamp":1489622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T00:00:00Z","timestamp":1489622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["HHSN 271201100029C"],"award-info":[{"award-number":["HHSN 271201100029C"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s11064-017-2227-7","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T03:58:06Z","timestamp":1489636686000},"page":"1904-1918","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy"],"prefix":"10.1007","volume":"42","author":[{"given":"Melissa L.","family":"Barker-Haliski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Billingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Huff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Handy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizvana","family":"Khaleel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenmei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Mau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy H.","family":"Pruess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan K.","family":"Underwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Vanegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misty D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,16]]},"reference":[{"issue":"4","key":"2227_CR1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jpeds.2012.03.059","volume":"161","author":"AC Modi","year":"2012","unstructured":"Modi AC, Ingerski LM, Rausch JR, Glauser TA, Drotar D (2012) White coat adherence over the first year of therapy in pediatric epilepsy. J Pediatr 161(4):695\u2013699. doi:\n                    10.1016\/j.jpeds.2012.03.059","journal-title":"J Pediatr"},{"issue":"6","key":"2227_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/1756285611417920","volume":"4","author":"CM Eddy","year":"2011","unstructured":"Eddy CM, Rickards HE, Cavanna AE (2011) The cognitive impact of antiepileptic drugs. Ther Adv Neurol Disord 4(6):385\u2013407. doi:\n                    10.1177\/1756285611417920","journal-title":"Ther Adv Neurol Disord"},{"key":"2227_CR3","unstructured":"Council NANDaSN (2015) Anticonvulsant Screening Program Report."},{"key":"2227_CR4","volume-title":"Wyllie\u2019s treatment of epilepsy","author":"M Barker-Haliski","year":"2015","unstructured":"Barker-Haliski M, White HS (2015) Antiepileptic drug development and experimental models. In: Wyllie E, Gidal BE, Goodkin HP (eds) Wyllie\u2019s treatment of epilepsy. 6th edn. Lippencott, Williams & Wilkins, Philadelphia","edition":"6th"},{"issue":"2213","key":"2227_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1126\/science.85.2213.525","volume":"85","author":"TJ Putnam","year":"1937","unstructured":"Putnam TJ, Merritt HH (1937) Experimental determination of the anticonvulsant properties of some phenyl derivatives. Science 85(2213):525\u2013526. doi:\n                    10.1126\/science.85.2213.525","journal-title":"Science"},{"key":"2227_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","volume":"47","author":"ME Barton","year":"2001","unstructured":"Barton ME, Klein BD, Wolf HH, White HS (2001) Pharmacological characterization of the 6\u00a0Hz psychomotor seizure model of partial epilepsy. Epilepsy Res 47:217\u2013227","journal-title":"Epilepsy Res"},{"key":"2227_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","volume":"244","author":"A Vezzani","year":"2013","unstructured":"Vezzani A, Aronica E, Mazarati A, Pittman QJ (2013) Epilepsy and brain inflammation. Exp Neurol 244:11\u201321. doi:\n                    10.1016\/j.expneurol.2011.09.033","journal-title":"Exp Neurol"},{"issue":"2\u20133","key":"2227_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.eplepsyres.2010.09.002","volume":"92","author":"NM Rowley","year":"2010","unstructured":"Rowley NM, White HS (2010) Comparative anticonvulsant efficacy in the corneal kindled mouse model of partial epilepsy: correlation with other seizure and epilepsy models. Epilepsy Res 92(2\u20133):163\u2013169","journal-title":"Epilepsy Res"},{"issue":"1","key":"2227_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0920-1211(98)00016-3","volume":"31","author":"A Matagne","year":"1998","unstructured":"Matagne A, Klitgaard H (1998) Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man. Epilepsy Res 31(1):59\u201371 pii]","journal-title":"Epilepsy Res"},{"key":"2227_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlw008","author":"JL Loewen","year":"2016","unstructured":"Loewen JL, Barker-Haliski ML, Dahle EJ, White HS, Wilcox KS (2016) Neuronal injury, gliosis, and glial proliferation in two models of temporal lobe epilepsy. J Neuropathol Exp Neurol. doi:\n                    10.1093\/jnen\/nlw008","journal-title":"J Neuropathol Exp Neurol"},{"issue":"9","key":"2227_CR11","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/epi.13476","volume":"57","author":"ML Barker-Haliski","year":"2016","unstructured":"Barker-Haliski ML, Vanegas F, Mau MJ, Underwood TK, White HS (2016) Acute cognitive impact of antiseizure drugs in naive rodents and corneal-kindled mice. Epilepsia 57(9):1386\u20131397. doi:\n                    10.1111\/epi.13476","journal-title":"Epilepsia"},{"issue":"3","key":"2227_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.eplepsyres.2006.02.004","volume":"69","author":"MA Rogawski","year":"2006","unstructured":"Rogawski MA (2006) Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res 69(3):273\u2013294. doi:\n                    10.1016\/j.eplepsyres.2006.02.004","journal-title":"Epilepsy Res"},{"issue":"4","key":"2227_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.eplepsyres.2014.02.013","volume":"108","author":"K Leclercq","year":"2014","unstructured":"Leclercq K, Matagne A, Kaminski RM (2014) Low potency and limited efficacy of antiepileptic drugs in the mouse 6\u00a0Hz corneal kindling model. Epilepsy Res 108(4):675\u2013683. doi:\n                    10.1016\/j.eplepsyres.2014.02.013","journal-title":"Epilepsy Res"},{"issue":"2\u20133","key":"2227_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.eplepsyres.2007.02.001","volume":"74","author":"MD Smith","year":"2007","unstructured":"Smith MD, Adams AC, Saunders GW, White HS, Wilcox KS (2007) Phenytoin- and carbamazepine-resistant spontaneous bursting in rat entorhinal cortex is blocked by retigabine in vitro. Epilepsy Res 74(2\u20133):97\u2013106. doi:\n                    10.1016\/j.eplepsyres.2007.02.001","journal-title":"Epilepsy Res"},{"issue":"3","key":"2227_CR15","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/0306-4522(94)00463-F","volume":"64","author":"F Suzuki","year":"1995","unstructured":"Suzuki F, Junier MP, Guilhem D, Sorensen JC, Onteniente B (1995) Morphogenetic effect of kainate on adult hippocampal neurons associated with a prolonged expression of brain-derived neurotrophic factor. Neuroscience 64(3):665\u2013674","journal-title":"Neuroscience"},{"issue":"3","key":"2227_CR16","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0306-4522(98)00401-1","volume":"89","author":"V Bouilleret","year":"1999","unstructured":"Bouilleret V, Ridoux V, Depaulis A, Marescaux C, Nehlig A, Le Gal La Salle G (1999) Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy. Neuroscience 89(3):717\u2013729","journal-title":"Neuroscience"},{"issue":"1","key":"2227_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0306-4522(02)00064-7","volume":"112","author":"V Riban","year":"2002","unstructured":"Riban V, Bouilleret V, Pham-Le BT, Fritschy JM, Marescaux C, Depaulis A (2002) Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Neuroscience 112(1):101\u2013111","journal-title":"Neuroscience"},{"issue":"6","key":"2227_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/cns.12523","volume":"22","author":"V Duveau","year":"2016","unstructured":"Duveau V, Pouyatos B, Bressand K, Bouyssieres C, Chabrol T, Roche Y, Depaulis A, Roucard C (2016) Differential effects of antiepileptic drugs on focal seizures in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy. CNS Neurosci Ther 22(6):497\u2013506. doi:\n                    10.1111\/cns.12523","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"2227_CR19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s13311-011-0039-z","volume":"8","author":"M Maroso","year":"2011","unstructured":"Maroso M, Balosso S, Ravizza T, Iori V, Wright CI, French J, Vezzani A (2011) Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 8(2):304\u2013315. doi:\n                    10.1007\/s13311-011-0039-z","journal-title":"Neurotherapeutics"},{"issue":"1","key":"2227_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.eplepsyres.2012.10.001","volume":"103","author":"M Bialer","year":"2013","unstructured":"Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS (2013) Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI). Epilepsy Res 103(1):2\u201330. doi:\n                    10.1016\/j.eplepsyres.2012.10.001","journal-title":"Epilepsy Res"},{"key":"2227_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0301-0082(97)00035-X","volume":"53","author":"W Loscher","year":"1997","unstructured":"Loscher W (1997) Animal models of intractable epilepsy. Prog Neurobiol 53:239\u2013258","journal-title":"Prog Neurobiol"},{"issue":"Suppl 7","key":"2227_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1046\/j.1528-1157.44.s7.10.x","volume":"44","author":"HS White","year":"2003","unstructured":"White HS (2003) Preclinical development of antiepileptic drugs: past, present, and future directions. Epilepsia 44(Suppl 7):2\u20138","journal-title":"Epilepsia"},{"issue":"1\u20132","key":"2227_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.eplepsyres.2012.10.003","volume":"104","author":"AK Srivastava","year":"2013","unstructured":"Srivastava AK, White HS (2013) Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats. Epilepsy Res 104(1\u20132):26\u201334. doi:\n                    10.1016\/j.eplepsyres.2012.10.003","journal-title":"Epilepsy Res"},{"issue":"7","key":"2227_CR24","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/epi.12234","volume":"54","author":"AK Srivastava","year":"2013","unstructured":"Srivastava AK, Alex AB, Wilcox KS, White HS (2013) Rapid loss of efficacy to the antiseizure drugs lamotrigine and carbamazepine: a novel experimental model of pharmacoresistant epilepsy. Epilepsia 54(7):1186\u20131194. doi:\n                    10.1111\/epi.12234","journal-title":"Epilepsia"},{"issue":"1","key":"2227_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0920-1211(98)00017-5","volume":"31","author":"JL Hellier","year":"1998","unstructured":"Hellier JL, Patrylo PR, Buckmaster PS, Dudek FE (1998) Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy. Epilepsy Res 31(1):73\u201384","journal-title":"Epilepsy Res"},{"key":"2227_CR26","doi-asserted-by":"crossref","unstructured":"Thomson KE, Modi A, Glauser TA, White HS (2017) The impact of nonadherence to antiseizure drugs on seizure outcomes in an animal model of epilepsy. Epilepsia In Press, New York","DOI":"10.1111\/epi.13742"},{"issue":"7","key":"2227_CR27","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/cns.12285","volume":"20","author":"G Orban","year":"2014","unstructured":"Orban G, Bombardi C, Marino Gammazza A, Colangeli R, Pierucci M, Pomara C, Pessia M, Bucchieri F, Benigno A, Smolders I, De Deurwaerdere P, Di Giovanni G (2014) Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats. CNS Neurosci Ther 20(7):651\u2013661. doi:\n                    10.1111\/cns.12285","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"2227_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.yebeh.2012.10.009","volume":"26","author":"H Hamid","year":"2013","unstructured":"Hamid H, Kanner AM (2013) Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?. Epilepsy Behav 26 (3):261\u2013265. doi:\n                    10.1016\/j.yebeh.2012.10.009","journal-title":"Epilepsy Behav"},{"issue":"8","key":"2227_CR29","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/glia.22285","volume":"60","author":"D Boison","year":"2012","unstructured":"Boison D (2012) Adenosine dysfunction in epilepsy. Glia 60(8):1234\u20131243. doi:\n                    10.1002\/glia.22285","journal-title":"Glia"},{"issue":"2","key":"2227_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/epi.13634","volume":"58","author":"M Bialer","year":"2017","unstructured":"Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS (2017) Progress report on new antiepileptic drugs: a summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII). Epilepsia 58(2):181\u2013221. doi:\n                    10.1111\/epi.13634","journal-title":"Epilepsia"},{"issue":"6","key":"2227_CR31","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.yebeh.2004.08.021","volume":"5","author":"M Bialer","year":"2004","unstructured":"Bialer M, Twyman RE, White HS (2004) Correlation analysis between anticonvulsant ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levels. Epilepsy Behav 5 (6):866\u2013872","journal-title":"Epilepsy Behav"},{"key":"2227_CR32","volume-title":"Probit analysis. A statistical treatment of the sigmoid response curve","author":"DJ Finney","year":"1952","unstructured":"Finney DJ (1952) Probit analysis. A statistical treatment of the sigmoid response curve. University Press, Cambridge"},{"key":"2227_CR33","first-page":"85","volume-title":"Antiepileptic drugs","author":"EA Swinyard","year":"1989","unstructured":"Swinyard EA, Woodhead JH, White HS, Franklin MR (1989) General principles: experimental selection, quantification, and evaluation of anticonvulsants. In: Levy RHM RH, Melrum B, Penry JK, Dreifuss FE (eds) Antiepileptic drugs. 3rd edn. Raven Press, New York, pp\u00a085\u2013102","edition":"3rd"},{"key":"2227_CR34","first-page":"99","volume-title":"Antiepileptic Drugs","author":"HS White","year":"1995","unstructured":"White HS, Woodhead JH, Franklin MR (1995) General principles: experimental selection, quantification, and evaluation of antiepileptic drugs. In: Levy RH, Mattson RH, Meldrum BS (eds) Antiepileptic Drugs. 4th edn. Raven Press, New York, pp\u00a099\u2013110","edition":"4th"},{"issue":"1\u20132","key":"2227_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF02229077","volume":"16","author":"HS White","year":"1995","unstructured":"White HS, Johnson M, Wolf HH, Kupferberg HJ (1995) The early identification of anticonvulsant activity: role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models. Ital J Neurol Sci 16(1\u20132):73\u201377","journal-title":"Ital J Neurol Sci"},{"key":"2227_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","volume":"32","author":"RJ Racine","year":"1972","unstructured":"Racine RJ (1972) Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281\u2013294","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"2227_CR37","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/jps.3030460322","volume":"46","author":"MS Dunham","year":"1957","unstructured":"Dunham MS, Miya TA (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J Amer Pharm Ass Sci Ed 46:208\u2013209","journal-title":"J Amer Pharm Ass Sci Ed"},{"issue":"3","key":"2227_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","volume":"32","author":"RJ Racine","year":"1972","unstructured":"Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32(3):281\u2013294","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"2","key":"2227_CR39","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1152\/jn.1997.78.2.1082","volume":"78","author":"HE Scharfman","year":"1997","unstructured":"Scharfman HE (1997) Hyperexcitability in combined entorhinal\/hippocampal slices of adult rat after exposure to brain-derived neurotrophic factor. J Neurophysiol 78(2):1082\u20131095","journal-title":"J Neurophysiol"},{"issue":"12","key":"2227_CR40","doi-asserted-by":"publisher","first-page":"19581967","DOI":"10.1111\/epi.13577","volume":"57","author":"ML Barker-Haliski","year":"2016","unstructured":"Barker-Haliski ML, Heck TD, Dahle EJ, Vanegas F, Pruess TH, Wilcox KS, White HS (2016) Acute treatment with minocycline, but not valproic acid, improves long-term behavioral outcomes in the Theiler\u2019s virus model of temporal lobe epilepsy. Epilepsia 57(12):1958\u20131967","journal-title":"Epilepsia"},{"key":"2227_CR41","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.114.222513","author":"ML Barker-Haliski","year":"2015","unstructured":"Barker-Haliski ML, Dahle EJ, Heck TD, Pruess TH, Vanegas F, Wilcox KS, White HS (2015) Evaluating an etiologically-relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic behavioral comorbidities in the theiler\u2019s murine encephalomyelitis virus mouse model. J Pharmacol Exp Ther. doi:\n                    10.1124\/jpet.114.222513","journal-title":"J Pharmacol Exp Ther"},{"key":"2227_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2014.09.019","author":"KE Thomson","year":"2014","unstructured":"Thomson KE, White HS (2014) A novel open-source drug-delivery system that allows for first-of-kind simulation of nonadherence to pharmacological interventions in animal disease models. J Neurosci Methods. doi:\n                    10.1016\/j.jneumeth.2014.09.019","journal-title":"J Neurosci Methods"},{"issue":"2","key":"2227_CR43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1523\/JNEUROSCI.17-02-00607.1997","volume":"17","author":"TV Dunwiddie","year":"1997","unstructured":"Dunwiddie TV, Diao L, Kim HO, Jiang JL, Jacobson KA (1997) Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus. J Neurosci 17(2):607\u2013614","journal-title":"J Neurosci"},{"issue":"3","key":"2227_CR44","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.taap.2012.08.015","volume":"264","author":"MR McGill","year":"2012","unstructured":"McGill MR, Williams CD, Xie Y, Ramachandran A, Jaeschke H (2012) Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicol Appl Pharmacol 264(3):387\u2013394. doi:\n                    10.1016\/j.taap.2012.08.015","journal-title":"Toxicol Appl Pharmacol"},{"key":"2227_CR45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fnmol.2016.00026","volume":"9","author":"D Boison","year":"2016","unstructured":"Boison D (2016) The biochemistry and epigenetics of epilepsy: focus on adenosine and glycine. Front Mol Neurosci 9:26. doi:\n                    10.3389\/fnmol.2016.00026","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"2227_CR46","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/0168-0102(89)90054-0","volume":"7","author":"W Janusz","year":"1989","unstructured":"Janusz W, Kleinrok Z (1989) The role of the central serotonergic system in pilocarpine-induced seizures: receptor mechanisms. Neurosci Res 7(2):144\u2013153","journal-title":"Neurosci Res"},{"issue":"1","key":"2227_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.0013-9580.2005.13404.x","volume":"46","author":"HL Grabenstatter","year":"2005","unstructured":"Grabenstatter HL, Ferraro DJ, Williams PA, Chapman PL, Dudek FE (2005) Use of chronic epilepsy models in antiepileptic drug discovery: the effect of topiramate on spontaneous motor seizures in rats with kainate-induced epilepsy. Epilepsia 46(1):8\u201314. doi:\n                    10.1111\/j.0013-9580.2005.13404.x","journal-title":"Epilepsia"},{"issue":"8","key":"2227_CR48","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/bjp.2008.198","volume":"154","author":"A Matagne","year":"2008","unstructured":"Matagne A, Margineanu DG, Kenda B, Michel P, Klitgaard H (2008) Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A. Br J Pharmacol 154(8):1662\u20131671. doi:\n                    10.1038\/bjp.2008.198","journal-title":"Br J Pharmacol"},{"issue":"18","key":"2227_CR49","doi-asserted-by":"publisher","first-page":"8075","DOI":"10.1021\/jm300965a","volume":"55","author":"DK Tosh","year":"2012","unstructured":"Tosh DK, Paoletta S, Deflorian F, Phan K, Moss SM, Gao ZG, Jiang X, Jacobson KA (2012) Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity. J Med Chem 55(18):8075\u20138090. doi:\n                    10.1021\/jm300965a","journal-title":"J Med Chem"},{"issue":"3","key":"2227_CR50","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3171\/2013.10.JNS13918","volume":"120","author":"HY Shen","year":"2014","unstructured":"Shen HY, Sun H, Hanthorn MM, Zhi Z, Lan JQ, Poulsen DJ, Wang RK, Boison D (2014) Overexpression of adenosine kinase in cortical astrocytes and focal neocortical epilepsy in mice. J Neurosurg 120(3):628\u2013638. doi:\n                    10.3171\/2013.10.JNS13918","journal-title":"J Neurosurg"},{"issue":"5","key":"2227_CR51","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/ana.410320504","volume":"32","author":"MJ During","year":"1992","unstructured":"During MJ, Spencer DD (1992) Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann Neurol 32(5):618\u2013624. doi:\n                    10.1002\/ana.410320504","journal-title":"Ann Neurol"},{"issue":"3","key":"2227_CR52","first-page":"487","volume":"19","author":"KK Borowicz","year":"2012","unstructured":"Borowicz KK, Piskorska B, Stepniak B, Czuczwar SJ (2012) Effects of fluoxetine on the anticonvulsant action of valproate and ethosuximide in mouse model of myoclonic convulsions. Ann Agric Environ Med 19(3):487\u2013490","journal-title":"Ann Agric Environ Med"},{"issue":"1","key":"2227_CR53","first-page":"83","volume":"58","author":"KK Borowicz","year":"2006","unstructured":"Borowicz KK, Stepien K, Czuczwar SJ (2006) Fluoxetine enhances the anticonvulsant effects of conventional antiepileptic drugs in maximal electroshock seizures in mice. Pharmacol Rep 58(1):83\u201390","journal-title":"Pharmacol Rep"},{"issue":"1","key":"2227_CR54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/WNR.0b013e3283413231","volume":"22","author":"LS Deshpande","year":"2011","unstructured":"Deshpande LS, DeLorenzo RJ (2011) Acetaminophen inhibits status epilepticus in cultured hippocampal neurons. Neuroreport 22(1):15\u201318. doi:\n                    10.1097\/WNR.0b013e3283413231","journal-title":"Neuroreport"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-017-2227-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-017-2227-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-017-2227-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:38:17Z","timestamp":1589722697000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-017-2227-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,16]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["2227"],"URL":"https:\/\/doi.org\/10.1007\/s11064-017-2227-7","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,16]]},"assertion":[{"value":"5 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}